• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.用于理解决定同工型选择性的结构特征的CYP1酶的适应性小配体。
ACS Med Chem Lett. 2018 Oct 29;9(12):1247-1252. doi: 10.1021/acsmedchemlett.8b00409. eCollection 2018 Dec 13.
2
[Inhibitory effect of flavonoids from Scutellariae Radix on human cytochrome P450 1A].[黄芩黄酮对人细胞色素P450 1A的抑制作用]
Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(3):566-573. doi: 10.19540/j.cnki.cjcmm.20181128.005.
3
Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations.CYP1A1、CYP1A2和CYP1B1之间底物特异性差异的表征:一种采用分子对接和分子动力学模拟的综合方法。
J Mol Recognit. 2016 Aug;29(8):370-90. doi: 10.1002/jmr.2537. Epub 2016 Feb 25.
4
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.鉴定主要植物大麻素、大麻二酚和大麻酚作为人细胞色素 P450 同工酶的亚型选择性和强效抑制剂。
Biochem Pharmacol. 2010 Jun 1;79(11):1691-8. doi: 10.1016/j.bcp.2010.01.028. Epub 2010 Feb 1.
5
Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.靶向CYP1的抑制剂和前体药物:癌症预防与治疗的新方法。
Curr Med Chem. 2014;21(5):519-52. doi: 10.2174/09298673113206660277.
6
Identification of Potent and Selective CYP1A1 Inhibitors via Combined Ligand and Structure-Based Virtual Screening and Their in Vitro Validation in Sacchrosomes and Live Human Cells.通过联合配体和基于结构的虚拟筛选鉴定有效的、选择性的 CYP1A1 抑制剂及其在 Sacchrosomes 和活人体细胞中的体外验证。
J Chem Inf Model. 2017 Jun 26;57(6):1309-1320. doi: 10.1021/acs.jcim.7b00095. Epub 2017 May 22.
7
Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.采用基于配体和基于结构的联合方法,剖析代表性因子 Xa 和凝血酶抑制剂的选择性结构决定因素。
J Chem Inf Model. 2011 Aug 22;51(8):1966-85. doi: 10.1021/ci200185q. Epub 2011 Aug 1.
8
Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches.通过计算机模拟方法深入了解苯并噻唑和噻唑并哌啶 γ 特异性抑制剂与磷酸肌醇 3-激酶 γ 的选择性机制。
Chem Biol Drug Des. 2019 May;93(5):818-831. doi: 10.1111/cbdd.13469. Epub 2019 Jan 11.
9
Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.三嗪衍生物作为ROCK1抑制剂的发现与优化:分子对接、分子动力学模拟及自由能计算
Mol Biosyst. 2013 Mar;9(3):361-74. doi: 10.1039/c2mb25408e. Epub 2013 Jan 23.
10
Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in Cancer.基于药物信息学方法设计新型蛋白激酶 B 通路抑制剂用于癌症治疗。
Curr Cancer Drug Targets. 2018;18(9):830-846. doi: 10.2174/1568009617666170623104540.

引用本文的文献

1
Proanthocyanidins inhibit CYP1B1 through mixed-type kinetics and stable binding in molecular dynamics simulations.原花青素通过混合型动力学抑制CYP1B1,并在分子动力学模拟中具有稳定结合。
Sci Rep. 2025 Aug 29;15(1):31877. doi: 10.1038/s41598-025-12781-2.
2
A context-based matched molecular pair analysis identifies structural transformations that reduce CYP1A2 inhibition.基于上下文的匹配分子对分析确定了可降低CYP1A2抑制作用的结构转变。
RSC Med Chem. 2025 May 2. doi: 10.1039/d4md01012d.
3
Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations.通过分子动力学模拟研究人 CYP1A1、CYP1A2 和 CYP1B1 活性部位的水合作用和结构适应性。
Int J Mol Sci. 2023 Jul 14;24(14):11481. doi: 10.3390/ijms241411481.
4
Computational Investigation of Ligand Binding of Flavonoids in Cytochrome P450 Receptors.细胞色素P450受体中黄酮类化合物配体结合的计算研究
Curr Pharm Des. 2022;28(45):3637-3648. doi: 10.2174/1381612829666221121151713.

本文引用的文献

1
Comparative assessment of strategies to identify similar ligand-binding pockets in proteins.比较评估鉴定蛋白质中相似配体结合口袋的策略。
BMC Bioinformatics. 2018 Mar 9;19(1):91. doi: 10.1186/s12859-018-2109-2.
2
Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.基于迄今报告的分子模拟研究对CYP1A亚家族酶的配体特异性因素的综述。
Molecules. 2017 Jul 8;22(7):1143. doi: 10.3390/molecules22071143.
3
Inhibitors of cytochrome P450 (CYP) 1B1.细胞色素 P450(CYP)1B1 抑制剂。
Eur J Med Chem. 2017 Jul 28;135:296-306. doi: 10.1016/j.ejmech.2017.04.042. Epub 2017 Apr 18.
4
Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes.黄酮类化合物和萘黄酮类化合物:在细胞色素P450 1家族酶调节中的广泛作用
ChemMedChem. 2016 Oct 6;11(19):2102-2118. doi: 10.1002/cmdc.201600316. Epub 2016 Aug 23.
5
Recent Structural Insights into Cytochrome P450 Function.细胞色素P450功能的最新结构见解
Trends Pharmacol Sci. 2016 Aug;37(8):625-640. doi: 10.1016/j.tips.2016.05.006. Epub 2016 Jun 4.
6
Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.发现靶点特异性或亚型选择性调节剂的策略。
J Med Chem. 2015 Oct 8;58(19):7611-33. doi: 10.1021/acs.jmedchem.5b00229. Epub 2015 Jul 1.
7
Cytochrome P450 1 family and cancers.细胞色素P450 1家族与癌症
J Steroid Biochem Mol Biol. 2015 Mar;147:24-30. doi: 10.1016/j.jsbmb.2014.11.003. Epub 2014 Nov 6.
8
Cytochrome P450 family 1 inhibitors and structure-activity relationships.细胞色素 P450 家族 1 抑制剂及其结构-活性关系。
Molecules. 2013 Nov 25;18(12):14470-95. doi: 10.3390/molecules181214470.
9
Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.靶向CYP1的抑制剂和前体药物:癌症预防与治疗的新方法。
Curr Med Chem. 2014;21(5):519-52. doi: 10.2174/09298673113206660277.
10
Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.药物混杂性在 PDB 中的体现:蛋白结合位点相似性是关键。
PLoS One. 2013 Jun 21;8(6):e65894. doi: 10.1371/journal.pone.0065894. Print 2013.

用于理解决定同工型选择性的结构特征的CYP1酶的适应性小配体。

Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.

作者信息

Lee Joo-Youn, Cho Hyunkyung, Thangapandian Sundarapandian, Lim Chaemin, Chun Young-Jin, Lee Yoonji, Choi Sun, Kim Sanghee

机构信息

College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea.

Chemical Data-Driven Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Korea.

出版信息

ACS Med Chem Lett. 2018 Oct 29;9(12):1247-1252. doi: 10.1021/acsmedchemlett.8b00409. eCollection 2018 Dec 13.

DOI:10.1021/acsmedchemlett.8b00409
PMID:30613334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6295865/
Abstract

Although several families of compounds have been identified as scaffolds for inhibitors of the CYP1 family, the isoform selectivity determining structural features has not been fully clarified at the molecular interaction level. We studied the CYP1 isoform selectivity for stilbenoid inhibitors using integrated induced fit docking and molecular dynamics simulations. The hydrophobic interactions with the specific phenylalanine residues in the F helix are correlated with inhibitory potency in the CYP1 family. Through this study, we found that the adaptable, small, and semirigid ligand is a promising starting point for the development of isoform-selective inhibitors and investigation of selectivity-determining features.

摘要

尽管已鉴定出几类化合物作为CYP1家族抑制剂的骨架,但在分子相互作用水平上,决定同工型选择性的结构特征尚未完全阐明。我们使用整合诱导契合对接和分子动力学模拟研究了芪类抑制剂对CYP1同工型的选择性。与F螺旋中特定苯丙氨酸残基的疏水相互作用与CYP1家族中的抑制效力相关。通过这项研究,我们发现适应性强、体积小且半刚性的配体是开发同工型选择性抑制剂和研究选择性决定特征的有前景的起点。